Rivaroxaban for the prevention of major adverse cardiovascular events in patients with coronary or peripheral artery disease

Future Cardiology, Ahead of Print.

Source: Future Cardiology - July 6, 2020 Category: Cardiology Authors: Matt Wheeler Noel Chan John Eikelboom Source Type: research